addiction medicine
‘Possible’ GLP-1 effects in substance use disorders
Despite “lots of interest” in possible reductions in alcohol and smoking, cost and side effects may present barriers to using popular weight loss drugs in addiction medicine Major studies have …
Looking into the vaping circus
Vaping, medicinal cannabis and more: a look at the highlights from the upcoming harm minimisation stream at Pharmacy Connect Not since the movement of codeine from an over-the-counter product to …
Synthetic opioids: the coming wave
Fentanyl has yet to fully enter Australia, but experts believe it is a matter of when, not if, it arrives on our shores. Is there a role for pharmacists in …
Being a part of the solution
Angelo Pricolo speaks about his experiences in treating addiction, his thoughts on the ‘War on Drugs’ and his thoughts on the future of harm minimisation In this podcast, Carlene McMaugh …
Question time
AJP will be presenting a harm minimisation panel discussion during APP2022, and we’re inviting you to ask questions We’re pleased to reveal an exciting new initiative that will take place …
AJP chats with… Angelo Pricolo
‘Greg Hunt, if you’re out there, please reconsider’: Talking about getting naloxone into more hands, harm minimisation and reducing stigma in the pharmacy… “The smallest side glance or comment, or …
Trial saves 21 lives
A leading pharmacist and expert in addiction medicine has welcomed the planned extension of Victoria’s supervised injecting program The Victorian Government has accepted all recommendations of the independent review of …